Name
osaühing Koosa Perearstikabinet
Registry code
10667248
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
01.08.2000 (24)
Financial year
01.01-31.12
Capital
40 000.00 €
Activity
86211 - Provision of general medical treatment
348 274 €
1 565 €
0%
2 655 €
(estimate is approximate)
21 449 €
5
Submitted
No tax arrears
7%
3%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ülle Lainurm 31.01.1959 (65) | 100% - 40 000.00 EEK | Board member | Direct ownership | |
| OÜ Ermitex Investeeringud 10616506 | - | - | - | Founder |
| 2019 29.04.2020 | 2020 11.05.2021 | 2021 24.05.2022 | 2022 18.05.2023 | 2023 04.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 219 152 € | 237 901 € | 284 628 € | 308 661 € | 348 274 € |
| Net profit (loss) for the period | 9 070 € | -1 352 € | -1 595 € | 1 096 € | 1 565 € |
| Profit Margin | 4% | -1% | -1% | 0% | 0% |
| Current Assets | 42 601 € | 42 832 € | 49 992 € | 45 943 € | 49 854 € |
| Fixed Assets | 6 339 € | 5 968 € | 3 555 € | 5 972 € | 3 933 € |
| Total Assets | 48 940 € | 48 800 € | 53 547 € | 51 915 € | 53 787 € |
| Current Liabilities | 15 206 € | 19 217 € | 27 759 € | 25 031 € | 32 338 € |
| Non Current Liabilities | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 33 734 € | 29 583 € | 25 788 € | 26 884 € | 21 449 € |
| Employees | 4 | 5 | 5 | 5 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 22 817.32 € | 23 708.48 € | 9 |
| 2023 Q4 | - | 19 415.85 € | 20 232.71 € | 9 |
| 2023 Q3 | - | 24 036.28 € | 23 981.48 € | 9 |
| 2023 Q2 | - | 16 750.28 € | 17 563.98 € | 9 |
| 2023 Q1 | - | 21 174.55 € | 22 311.83 € | 9 |
| 2022 Q4 | - | 16 292.15 € | 17 105.31 € | 9 |
| 2022 Q3 | - | 20 337.66 € | 21 406.77 € | 8 |
| 2022 Q2 | - | 20 619.24 € | 21 134.7 € | 8 |
| 2022 Q1 | - | 18 613.71 € | 19 659.48 € | 8 |
| 2021 Q4 | - | 16 117.49 € | 17 001.72 € | 8 |
| 2021 Q3 | - | 21 578.6 € | 22 844.59 € | 8 |
| 2021 Q2 | - | 15 068.44 € | 15 954.49 € | 8 |
| 2021 Q1 | - | 15 852.21 € | 15 949.9 € | 8 |
| 2020 Q4 | - | 12 668.21 € | 13 060.27 € | 8 |
| 2020 Q3 | - | 17 631.58 € | 18 611.06 € | 8 |
| 2020 Q2 | - | 13 543.75 € | 14 240.42 € | 8 |
| 2020 Q1 | - | 13 869.82 € | 14 354.1 € | 9 |
